Recombinant human serum albumin from Oryza sativa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human serum albumin from Oryza sativa, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Recombinant Human Serum Albumin From Oryza Sativa In Patients With Hypoalbuminemia and/or Hypovolemia Requiring Urgent Treatment